Summary of Analytical Method for Quantitative Estimation of Fingolimod and Fingolimod Phosphate from Human Whole Blood Samples

Similar documents
Pharmacologyonline 1: (2010) Newsletter Mohan et al.

The Analysis of Isotopically Labeled Propylene Glycol in ecigarettes

Chapter VI. Development and validation of an LC-MS/MS method for the determination of Montelukast in human plasma

vii LIST OF TABLES TABLE NO DESCRIPTION PAGE 1.1 System Suitability Parameters and Recommendations Acidic and Alkaline Hydrolysis 15

Journal of Pharmaceutical and Bioanalytical Science

Pharmacophore 2014, Vol. 5 (5), USA CODEN: PHARM7 ISSN Pharmacophore. (An International Research Journal)

Update on ANVISA Bioanalytical Method Validation (BMV) Guideline

Quantitation by High Resolution Mass Spectrometry: Case Study of TOF MS for the Quantitation of Allopurinol from Human Plasma

SCIEX Vitamin D 200M Assay for the Topaz System

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE

DKK-1 ELISA, Cat.No. BI For the quantitative determination of DKK-1 in human serum

HIGH THROUGHPUT LC-MS/MSMETHOD FOR THE QUANTITATION OF LINAGLIPTIN IN HUMAN PLASMA BY SOLID PHASE EXTRACTION USING 96 WELL PLATE FORMAT

Quantification of Budesonide Using UPLC and Xevo TQ-S

Highly sensitive simultaneous quantitative analysis of estrone and equilin from plasma using LC/MS/MS

A New Stability-Indicating and Validated RP-HPLC Method for the Estimation of Liraglutide in Bulk and Pharmaceutical Dosage Forms

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

CHAPTER II DETERMINATION OF THE ANTICONVULSANT FELBAMATE IN PLASMA SAMPLES BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY

Research Article. Liquid-liquid extraction method for Ziprasidone (ZRS) bioanalysis by using ZRS-D 8 (stable isotope) as internal standard

CHAPTER 3: ANALYTICAL METHOD DEVELOPMENT AND VALIDATION

Tentu Nageswara Rao et al. / Int. Res J Pharm. App Sci., 2012; 2(4): 35-40

Bioanalytical Issues when. Brigitte Pellerin Bioanalytical Associate Director

Reducing Sample Volume and Increasing Sensitivity for the Quantification of Human Insulin and 5 Analogs in Human Plasma Using ionkey/ms

VALIDATED LIQUID CHROMATOGRAPHIC ULTRA VIOLET METHOD FOR THE QUANTIZATION OF LEVETIRACETAM IN HUMAN PLASMA USING LIQUID LIQUID EXTRACTION

Comprehensive Forensic Toxicology Screening in Serum using On-Line SPE LC-MS/MS

Institute of Toxicology Clinical Toxicology and Pharmacology Berliner Betrieb für Zentrale Gesundheitliche Aufgaben, Berlin

Journal of Chemical and Pharmaceutical Research, 2012, 4(1): Research Article

Title: Pharmacokinetics of daikenchuto, a traditional Japanese medicine (Kampo) after. single oral administration to healthy Japanese volunteers

International Journal of Pharma and Bio Sciences DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF STRONTIUM RANELATE IN SACHET

Run 1 Run 2 TDP PLP TDP PLP. 3.0e5 2.8e5 2.2e5. 2.6e5 2.4e5. 2.2e5 2.0e5. Intensity, cps. 1.8e5 1.6e5 1.4e5 1.2e5 1.0e5 4.0e4. 2.0e e5 1.

HUMAN LIVER SLICE EXPERIMENT 1 Effects of Propylene Glycol on Ethylene Glycol Metabolism

Available Online through Research Article

Abstract. Introduction

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

Development and Validation of a Simultaneous HPLC Method for Quantification of Amlodipine Besylate and Metoprolol Tartrate in Tablets

CHAPTER 2 SIMULTANEOUS DETRMINATION OF ANASTROZOLE AND TEMOZOLOMIDE TEMOZOLOMIDE CAPSULES 20 MG AND ANASTROZOLE TABLETS 1 MG

Journal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

Pelagia Research Library

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Analytical Method Development and Validation for the Estimation of Guaifenesin and Dextromethorphan by RP-HPLC

Development and Validation of a New Uv Method for the Analysis of Rebamipide

Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

5.1 Summary. Summary & Conclusions

A NOVEL METHOD OF M/Z DRIFT CORRECTION FOR OA-TOF MASS SPECTROMETERS BASED ON CONSTRUCTION OF LIBRARIES OF MATRIX COMPONENTS.

NOVEL RP-HPLC METHOD. B.Lakshmi et a. concentration range KEY INTRODUCTION. Diltiazem is used to. . It works by of contractionn of the. (dilate).

IJRPC 2011, 1(4) Rohan et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

Journal of Chromatography B

Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations

Rapid determination of phosphate and citrate in carbonated soft drinks using ion chromatography

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

Accuracy and Precision. Intra- and inter-assay accuracy and precision for both rifapentine

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

International Journal of Biological and Medical Sciences

Development and Validation of a Polysorbate 20 Assay in a Therapeutic Antibody Formulation by RP-HPLC and Charged Aerosol Detector (CAD)

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION

Development and validation of RP-HPLC method for simultaneous estimation of gliclazide and metformin in pure and tablet dosage form

receptor (HER 2- ) advanced breast cancer 2.

QMS TACROLIMUS APPLICATION BECKMAN COULTER AU480 /AU680 /AU5800

Analysis of drugs of abuse in biological matrix using Time of Flight technology

Pankti M. Shah et al, Asian Journal of Pharmaceutical Technology & Innovation, 04 (17); 2016; 07-16

USING THE ACCESS AMH ASSAY IN YOUR LABORATORY

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

METHOD VALIDATION CASE

Pelagia Research Library

Development and Validation of Multiresidue Pesticide Methods at FDA/CFSAN

Isocratic Reversed Phase Liquid Chromatographic Method Validation for the Determination of Cilostazol in Pure and Formulations

Development and Validation of RP-HPLC Method for the Estimation of Gemigliptin

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Results and Discussion

Determination of Clarithromycin in Human Plasma by LC-EI Tandem Mass Spectrometry: Application to Bioequivalence Study

Development and Validation of Stability Indicating HPTLC Method for Estimation of Seratrodast

SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine

Determination of propranolol in dog plasma by HPLC method

Polymer Technology Systems, Inc. CardioChek PA Comparison Study

Determination of 6-Chloropicolinic Acid (6-CPA) in Crops by Liquid Chromatography with Tandem Mass Spectrometry Detection. EPL-BAS Method No.

A simple validated RP-HPLC method for quantification of sumatriptan succinate in bulk and pharmaceutical dosage form

Venkateswara University, Tirupati , India.

New RP - HPLC Method for the Determination of Valproic acid in Human Plasma

Research Article. ISSN Available online at 746

Determination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography

Drug development of highly potent therapeutic peptides Regulated microdose Bioanalysis

DIHYDROSTREPTOMYCIN and STREPTOMYCIN First draft prepared by Lynn G. Friedlander, Rockville, MD, USA Rainer W. Stephany, Bilthoven, The Netherlands

Fully automated sensitive determination of immunosuppressant drugs in whole blood, using high quality internal standardization

Rapid and Accurate LC-MS/MS Analysis of Nicotine and Related Compounds in Urine Using Raptor Biphenyl LC Columns and MS-Friendly Mobile Phases

LC-MS/MS Method for the Determination of Tenofovir from Plasma

A Practical Example of CLSI C60 in Action: Vitamins and Hormones

LCMS APPLICATIONS TCFS LAB. Applications of Triple Quadrupole LC/MS/MS in a Forensic Toxicology Laboratory CURRENT LCMS ANALYTES

Development and validation of UV-visible spectrophotometric method for estimation of rifapentine in bulk and dosage form

The Investigation of Factors Contributing to Immunosuppressant Drugs Response Variability in LC-MS/MS Analysis


Received: / Revised: / Accepted:

Transcription:

Fingolimod Whole Blood Analysis Summary of Analytical Method for Quantitative Estimation of Fingolimod and Fingolimod Phosphate from Human Whole Blood Samples Study Detail: - Determination of Fingolimod and Finglomod Phosphate from human Whole Blood samples after administration of x. mg Capsules of Fingolimod to healthy human subjects Bioanalytical method for quantitative estimation of Fingolimod and Finglomod Phosphate from human whole blood samples was developed and validated as per EMEA/US FDA guidelines for Bioanalytical method validation using LC-MS/MS (API-) Matrix: Human whole blood Matrix Volume: µl Fingolimod Calibration range.pg/ml to. pg/ml Sample ID minal Concentration (pg/ml) Accurac y (n=) CS.. QC samples.,. and. pg/ml Calibration curve plot MV_RUN.rdb (Sapropterin): "Linear" Regression (" / (x * x)" weighting): y =. x + -. (r =.)....... CS.. CS.. CS.. Analyte Area / IS Area........... CS....... CS.... Analyte Conc. / IS Conc. CS.. CS.. Slope=., Intercept=-., Regression =., Curve Type= Linear Regression, Weighting factor = /x Method is Precise and Accurate over the range of.pg/ml to.pg/ml, The information in this document is provided by Clinical Research Services of Reliance Life Sciences Pvt. Ltd. ( CRS ) and the contents, including all figures, tables, and drawings, are the intellectual property of CRS. Forwarding or reproduction of this document or parts thereof, regardless of reason or form, is not Page of

Fingolimod Method Validation Summary Selectivity interference observed in out of different lots of human plasma. Specificity (Cross reactivity) significant interference was observed at the RT of both Analyte and IS. carry over is observed for analyte and Injector Carryover Test internal standard. carry over is observed for analyte and internal standard for different instrument. Within-run accuracy QC % minal value. to. Within run precision QC Coefficient of variation. to.% Extended run accuracy QC % minal value. to.% Extended run precision QC Coefficient of variation. to.% Between run accuracy QC % minal value. to. Between run precision QC Coefficient of variation. to.% Ruggedness- Different analyst: accuracy QC % minal value. to. Ruggedness- Different analyst: precision QC Coefficient of variation. to.% Ruggedness- Different column: accuracy QC % minal value. to. Ruggedness- Different column: precision QC Coefficient of variation. to.% Recovery of analyte. to.% Recovery of Internal standard.% Dilution Integrity accuracy QC % minal value. to. Dilution Integrity precision QC Coefficient of variation. to.% Re-injection Reproducibility Analyte A response was reproducible. Anticoagulant effect accuracy QC % minal value. to. Anticoagulant effect precision QC Coefficient of variation. to.% Matrix effect precision (Internal Standard normalized MF for LQC) Coefficient of variation.% Matrix effect precision (Internal Standard normalized MF for HQC) Coefficient of variation.% Short term stability of analyte in stock solution on bench Mean % Change after hours minutes is -. stock solution on bench Mean % Change after hours minutes is -. Short term stability of analyte in working Mean % Change after hours Page of

Sample Name: "MB_RP" Sample ID: "" File: "MV_RUN RES_.wiff" Peak Name: "Fingolimod" Mass(es): "./. amu". Concentration:. pg/ml Acq. Time: :: PM.............. Sample Name: "MB_RP" Sample ID: "" File: "MV_RUN RES_.wiff" Peak Name: "Fingolimod D(IS)" Mass(es): "./. amu" Concentration:. pg/ml. Acq. Time: :: PM.................................................................................. solution on bench minutes is -. working solution on bench Mean % Change after hours minutes is -. Freeze and thaw stability at -± C after cycles QC Mean % Change -. to. Coolant stability of analyte in matrix in dry ice QC Mean % Change after hours minutes is. to. Autosampler stability at C QC Mean % Change after hours minutes is. to. Bench Top stability of analyte in matrix at room temperature QC Mean % Change after hours minutes is. to. Long Term stability of analyte in stock solution at - C Mean % Change is -. after days stock solution at - C Mean % Change is -. after days Long Term stability of analyte in working solution at - C Mean % change is -. after days working solution at - C Mean % Change is -. after days Fingolimod Figure Blank: Human whole blood.. Page of

Sample Name: "CS_RP" Sample ID: "" File: "MV_RUN RES_.wiff" Peak Name: "Fingolimod" Mass(es): "./. amu" Concentration:. pg/ml Calculated Conc:. pg/ml Acq. Time: :: PM ise Threshold:. cps Area Threshold:. cps Sep. Width:. Exp. Adj. Ratio:. Exp. Val. Ratio:. Use Relative RT: Retention Time:. min Start Time:. min End Time:. min Sample Name: "CS_RP" Sample ID: "" File: "MV_RUN RES_.wiff" Peak Name: "Fingolimod D(IS)" Mass(es): "./. amu" Concentration:. pg/ml Acq. Time: :: PM ise Threshold:. cps Area Threshold:. cps Sep. Width:. Exp. Adj. Ratio:. Exp. Val. Ratio:. Use Relative RT: Retention Time:. min Start Time:. min End Time:. min.. LLOQ:.pg/ml Proc. Algorithm: Analyst Classic Sep.. Exp. Peak Ratio:. RT Window:. sec Expected RT:. min Area: counts.e+ cps Proc. Algorithm: Analyst Classic Sep.. Exp. Peak Ratio:. RT Window:. sec Expected RT:. min Area: counts.e+ cps Fingolimod Phospahte: Calibration range.pg/ml to.pg/ml Sample ID minal Concentration (pg/ml) Accuracy (n=) CS.. QC samples.,. and. pg/ml Calibration curve plot MV_RUN.rdb (Sapropterin): "Linear" Regression (" / (x * x)" weighting): y =. x + -. (r =.)...... CS..... CS.. CS.. Analyte Area / IS Area........ CS...... CS...... CS.. Analyte Conc. / IS Conc. CS.. Slope=., Intercept=- -., Regression =., Curve Type= Linear Regression, Weighting factor = /x Method is Precise and Accurate over the range of.pg/ml to.pg/ml, Page of

Fingolimod Phospahte Method Validation Summary Selectivity interference observed in out of different lots of human plasma. Specificity (Cross reactivity) significant interference was observed at the RT of both Analyte and IS. carry over is observed for analyte and Injector Carryover Test internal standard. carry over is observed for analyte and internal standard for different instrument. Within-run accuracy QC % minal value. to. Within run precision QC Coefficient of variation. to.% Extended run accuracy QC % minal value. to. Extended run precision QC Coefficient of variation. to.% Between run accuracy QC % minal value. to. Between run precision QC Coefficient of variation. to.% Ruggedness- Different analyst: accuracy QC % minal value. to. Ruggedness- Different analyst: precision QC Coefficient of variation. to.% Ruggedness- Different column: accuracy QC % minal value. to. Ruggedness- Different column: precision QC Coefficient of variation. to.% Recovery of analyte.to.% Recovery of Internal standard.% Dilution Integrity accuracy QC % minal value. to. Dilution Integrity precision QC Coefficient of variation. to.% Re-injection Reproducibility Analyte B response was reproducible. Anticoagulant effect accuracy QC % minal value. to. Anticoagulant effect precision QC Coefficient of variation. to.% Matrix effect precision (Internal Standard Coefficient of variation.% normalized MF for LQC) Matrix effect precision (Internal Standard Coefficient of variation.% normalized MF for HQC) Short term stability of analyte in stock solution on bench Mean % Change after hours minutes is -. stock solution on bench Mean % Change after hours minutes is -. Short term stability of analyte in working solution on bench Mean % Change after hours minutes is -. working solution on bench Mean % Change after hours minutes is -. Freeze and thaw stability at -± C after QC Mean % Change -. to. Page of

Sample Name: "MB_RP" Sample ID: "" File: "MV_RUN RES_.wiff" Peak Name: "Fingolimod phosphate" Mass(es): "./. amu" Concentration:. pg/ml Acq. Time: :: PM.............. Sample Name: "MB_RP" Sample ID: "" File: "MV_RUN RES_.wiff" Peak Name: "Fingolimod phosphate D(IS)" Mass(es): "./. amu". Concentration:. pg/ml Acq. Time: :: PM............... cycles Coolant stability of analyte in matrix in dry ice Autosampler stability at C Bench Top stability of analyte in matrix at room temperature Long Term stability of analyte in stock solution at - C stock solution at - C Long Term stability of analyte in working solution at - C working solution at - C QC Mean % Change after hours minutes is -. to. QC Mean % Change after hours minutes is. to. QC Mean % Change after hours minutes is -. to. Mean % Change is -. after days Mean % Change is -. after days Mean % Change is -. after days Mean % Change is -. after days Fingolimod phosphate figure: Blank: Human whole blood LLOQ:.pg/ml Page of

Sample Name: "CS_RP" Sample ID: "" File: "MV_RUN RES_.wiff" Peak Name: "Fingolimod phosphate" Mass(es): "./. amu" Concentration:. pg/ml Calculated Conc:. pg/ml Acq. Time: :: PM Proc. Algorithm: Analyst Classic ise Threshold:. cps Area Threshold:. cps Sep. Width:. Sep.. Exp. Peak Ratio:. Exp. Adj. Ratio:. Exp. Val. Ratio:. RT Window:. sec Expected RT:. min Use Relative RT: Retention Time:. min Area: counts.e+ cps Start Time:. min End Time:. min. Sample Name: "CS_RP" Sample ID: "" File: "MV_RUN RES_.wiff" Peak Name: "Fingolimod phosphate D(IS)" Mass(es): "./. amu" Concentration:. pg/ml Acq. Time: :: PM Proc. Algorithm: Analyst Classic ise Threshold:. cps Area Threshold:. cps Sep. Width:. Sep.. Exp. Peak Ratio:. Exp. Adj. Ratio:. Exp. Val. Ratio:. RT Window:. sec Expected RT:. min Use Relative RT: Retention Time:. min Area: counts.e+ cps Start Time:. min End Time:. min.... Page of